📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-08 20:05
0 analysed today
0
Today
133,610
All-time analysed
40,129
Positive
6,284
Negative
79,377
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Photon Capital to Rebrand as Inference Platforms; Proposes Rs 500 Cr Borrowing Limit
Photon Capital reported a turnaround in Q1 FY27 with a net profit of Rs 0.16 Cr on revenue of Rs 0.25 Cr, compared to a loss in the previous year. Following a recent change in management via an open offer, the board has proposed a massive increase in borrowing and investment limits to Rs 500 Cr each, which is approximately 62.5x the company's current net worth of Rs 8 Cr. The company plans to rebrand as 'Inference Platforms Limited' and alter its main business objects, signaling a significant strategic pivot. Two employee stock schemes (ESOS and ESPS) for 81,620 shares each were also approved to incentivize the new management team.
Confidence: HIGH
What changedThe company is undergoing a complete structural overhaul including a name change, a pivot in business objects, and a massive expansion of its capital-raising authority following a change in promoter control.
Why it mattersThe proposed Rs 500 Cr borrowing and investment limits suggest the new management intends to transform this micro-cap entity into a significantly larger operating platform, moving away from its current stagnant financial state.
Q1 FY27 Revenue: Rs 0.25 CrQ1 FY27 Net Profit: Rs 0.16 CrProposed Borrowing Limit: Rs 500 CrLimit vs Net Worth Ratio: 62.5xESOP/ESPS Total Shares: 1,63,240
📅 Short termThe turnaround in profitability and aggressive expansion plans are likely to be viewed positively by the market, though the stock has already seen significant recent appreciation.
📈 Long termHighly significant; the company is effectively being re-launched. Success depends entirely on the execution of the new business model under the 'Inference Platforms' identity.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High execution risk for new business pivot
- Potential for massive leverage (Rs 500 Cr debt vs Rs 8 Cr equity)
- Dilution risk from ESOP/ESPS schemes
Key Highlights
Q1 FY27 Revenue rose to Rs 0.25 Cr from nil in the year-ago period.
Proposed borrowing limit increased to Rs 500 Cr, representing 62.5x the current Net Worth of Rs 8 Cr.
Company name change to 'Inference Platforms Limited' approved subject to shareholder and MCA clearance.
Net Profit for Q1 FY27 reached Rs 0.16 Cr vs a loss of Rs 0.10 Cr in Q1 FY26.
Approved ESOP and ESPS schemes for 81,620 shares each at an exercise price not less than Rs 10 face value.
👀 What to Watch
Monitor the 41st AGM on September 21, 2026, for shareholder approval of the name change and borrowing limits. Investors should specifically look for the updated 'Main Object Clause' to understand the new business direction under the 'Inference Platforms' brand.
Photon Capital reports ₹16.11 Lakh Q1 profit; proposes ₹500 Cr borrowing limit and name change
Photon Capital Advisors reported a turnaround in Q1 FY27 (ending June 2026) with a net profit of ₹16.11 Lakhs, compared to a loss of ₹10.20 Lakhs in the same quarter last year. The board has proposed a massive increase in borrowing limits to ₹500 Cr, which is approximately 62.5x the company's current net worth of ₹8 Cr. Following a recent management change via an open offer, the company plans to rename itself to 'Inference Platforms Limited' and alter its main object clause, signaling a significant business pivot. Additionally, the board approved new ESOP and ESPS schemes covering 81,620 shares each to incentivize employees.
Confidence: HIGH
What changedThe company has transitioned to profitability and is seeking to pivot its business model, evidenced by a proposed name change, object clause alteration, and a massive increase in borrowing capacity.
Why it mattersThe proposed ₹500 Cr borrowing limit suggests the new management intends to aggressively scale or acquire assets, which could fundamentally change the company's tiny ₹51 Cr market cap profile.
Net Profit (Q1 FY27): ₹16.11 LakhsProposed Borrowing Limit: ₹500 CrBorrowing Limit vs Net Worth: 62.5xTotal Income (Q1 FY27): ₹60.29 LakhsESOP Shares: 81,620 units
📅 Short termThe turnaround to profitability and ambitious expansion plans are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe company is undergoing a structural transformation; long-term value depends entirely on the execution of the new 'Inference Platforms' business strategy and the utilization of new debt.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk of new business model
- High potential leverage if ₹500 Cr borrowing is fully utilized
- Dilution risk from ESOP/ESPS schemes
Key Highlights
Net Profit turned positive at ₹16.11 Lakhs for Q1 FY27 vs a loss of ₹10.20 Lakhs in Q1 FY26.
Proposed borrowing limit increase to ₹500 Cr, a massive jump relative to the current ₹8 Cr net worth.
Company to be renamed 'Inference Platforms Limited' subject to shareholder and MCA approval.
Revenue from operations reached ₹25.00 Lakhs in Q1 FY27 compared to nil in Q1 FY26.
Approved ESOP and ESPS schemes for 81,620 shares each at an exercise price not less than ₹10 face value.
👀 What to Watch
Monitor the AGM on September 21, 2026, for shareholder approval of the name change and the ₹500 Cr borrowing limit. Investors should seek clarity on the new business model under the 'Inference Platforms' brand and how the proposed capital will be deployed.
Photon Capital to Rebrand as Inference Platforms; Proposes ₹500 Cr Borrowing Limit
Photon Capital Advisors reported a turnaround in Q1 FY27 with a net profit of ₹0.16 Cr compared to a loss of ₹0.10 Cr in the previous year's quarter. The board has approved a massive increase in borrowing and investment limits to ₹500 Cr each, which is approximately 62.5x the company's current net worth of ₹8 Cr. The company is also rebranding to 'Inference Platforms Limited' and altering its main object clause, signaling a major business pivot following a recent management change. Additionally, two employee stock schemes (ESOS and ESPS) covering 81,620 shares each were approved.
Confidence: HIGH
What changedThe company is undergoing a complete structural pivot including a name change, a new business objective, and a massive increase in capital borrowing/investment limits under new management.
Why it mattersFor a micro-cap company with a ₹51 Cr market cap and historically negligible revenue, the proposed ₹500 Cr borrowing limit and rebranding suggest a high-stakes shift into a new industry (likely technology/platforms).
Q1 FY27 Revenue: ₹25.00 LakhsQ1 FY27 Net Profit: ₹16.11 LakhsProposed Borrowing Limit: ₹500 CrLimit vs Net Worth Ratio: ~62.5xESOP/ESPS Share Count: 81,620 each
📅 Short termThe stock may see volatility as the market reacts to the rebranding and the scale of the proposed financial limits, though these are subject to shareholder approval in September.
📈 Long termThe structural significance is high; the company is effectively being rebooted. Success depends entirely on the execution of the new business model under the 'Inference Platforms' brand.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Extreme leverage risk (₹500 Cr limit vs ₹8 Cr net worth)
- Execution risk of new business pivot
- Potential equity dilution from ESOP/ESPS schemes
Key Highlights
Q1 FY27 revenue from operations rose to ₹25.00 Lakhs from zero in the year-ago quarter.
Proposed borrowing limit increased to ₹500 Cr, representing over 6,000% of the current net worth.
Company to be renamed 'Inference Platforms Limited' subject to shareholder and MCA approval.
Approved ESOS and ESPS 2026 schemes for 81,620 shares each at a minimum exercise price of ₹10.
Net profit for the quarter ended June 2026 stood at ₹16.11 Lakhs vs a loss of ₹10.20 Lakhs in June 2025.
👀 What to Watch
Investors should closely monitor the 41st AGM on September 21, 2026, specifically for details on the 'Alteration of Main Object Clause' to understand the new business direction and the planned utilization of the ₹500 Cr borrowing headroom.
